In vivo data overall agreed with the in vitro results, showing increased expression of CD80, CD86, MHC-II, and GBP5 indicative of M1-like activation in tumor grafts not depleted of macrophages (Fig. 6K). The gene discussed is CD86; the disease is neoplasm.